New England Journal of Medicine · 1988 · 669 citations · 38 references
Life SciencesImmunologyOncologyCancer ImmunologyMolecular VirologyTumor ImmunologyImmunoglobulin Gene RearrangementLymphoid NeoplasmsLymphoid TumorsOncogenic VirusesT Cell BiologyTumor-infiltrating LymphocytesDna In Situ HybridizationEpstein-barr Virus - Associated Lymphoid NeoplasmsEpstein-barr Virus - Associated MalignanciesHematologic AbnormalitiesHematologic NeoplasiaLymphocyte SubtypesProliferation AssaysViral Tumor Antigens
Fatal T-cell lymphomas developed in three patients with a chronic illness manifested by fever, pneumonia, dysgammaglobulinemia, hematologic abnormalities, and extraordinarily high titers of antibody to the Epstein-Barr virus (EBV) capsid antigen (greater than 10,000) and early antigen (greater than 640) but low titers to the EBV nuclear antigen (less than or equal to 40). To understand the pathogenesis of these tumors better, we determined the immunophenotype of the tumor cells and analyzed tumor-cell DNA for EBV genomes and for lymphoid-cell gene rearrangements. More than 80 percent of the cells in tumors had an activated helper T-cell phenotype (T4, T11, la positive). The EBV genome was found by in situ hybridization in tumor tissue from each patient. Southern blot assay of DNA digests from one patient showed the same pattern as that of the EBV-infected marmoset line, B95-8. DNA digests from two patients showed a monoclonal proliferation of T cells determined on the basis of uniform T-cell-receptor gene rearrangements and a single band for the joined termini of the EBV genome. We conclude that EBV may infect T cells and contribute to lymphomas in selected patients with severe EBV infections.
38
Functional subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL1.
Susan Smith, M H Brown, D J Rowe et al. · PubMed · 1986 · 521 citations